Literature DB >> 15183145

IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients.

Paloma García de la Peña-Lefebvre1, Youri Chanseaud, Mathieu C Tamby, Joseph Reinbolt, Frédéric Batteux, Yannick Allanore, André Kahan, Olivier Meyer, Olivier Benveniste, Olivier Boyer, Loïc Guillevin, Marie-Christophe Boissier, Luc Mouthon.   

Abstract

We have analyzed antibody (Ab) reactivities of patients with limited systemic sclerosis (SSc) and anti-centromere Ab, patients with diffuse SSc and anti-topoisomerase 1 (anti-topo 1) Ab, patients with diffuse SSc without anti-topo 1 or anti-centromere Ab and age- and gender-matched healthy controls with normal human tissue and endothelial cell (EC) antigens. IgG reactivities with tissue antigens differed significantly between patients with anti-topo 1 Ab and patients with anti-centromere Ab. One 100-kDa band identified as topoisomerase 1 in macrovascular and microvascular EC extracts was recognized by IgG from patients with anti-topo 1 Ab and 50% of patients without specific Ab. IgG from patients with limited SSc and anti-centromere Ab, but not those of other patients or controls specifically recognized a 80-kDa band only in microvascular EC. Our results indicate that Ab from patients with limited or diffuse SSc with or without anti-topo 1 Ab exhibit specific and mutually exclusive reactivity patterns.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15183145     DOI: 10.1016/j.clim.2004.01.005

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  14 in total

1.  Association of Fcγ receptor IIIA variant with a subset of anti-topoisomerase I-positive patients in systemic sclerosis: a descriptive pilot study.

Authors:  J Magnant; M Ohresser; Y Allanore; M de Monte; M Lafosse-Marin; D Degenne; J L Guilmot; H Watier; E Diot
Journal:  Rheumatol Int       Date:  2011-07-23       Impact factor: 2.631

2.  Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud's phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway.

Authors:  Chieh-Yu Shen; Ko-Jen Li; Pei-Hsuan Lai; Chia-Li Yu; Song-Chou Hsieh
Journal:  Clin Rheumatol       Date:  2017-09-23       Impact factor: 2.980

3.  Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension.

Authors:  M C Tamby; Y Chanseaud; M Humbert; J Fermanian; P Guilpain; P Garcia-de-la-Peña-Lefebvre; S Brunet; A Servettaz; B Weill; G Simonneau; L Guillevin; M C Boissier; L Mouthon
Journal:  Thorax       Date:  2005-09       Impact factor: 9.139

4.  Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis.

Authors:  A Servettaz; P Guilpain; C Goulvestre; C Chéreau; C Hercend; C Nicco; L Guillevin; B Weill; L Mouthon; F Batteux
Journal:  Ann Rheum Dis       Date:  2007-03-15       Impact factor: 19.103

Review 5.  Antiendothelial cells autoantibodies in vasculitis-associated systemic diseases.

Authors:  Philippe Guilpain; Luc Mouthon
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

Review 6.  Current concepts in normal and defective angiogenesis: implications for systemic sclerosis.

Authors:  Mary Jo Mulligan-Kehoe; Michael Simons
Journal:  Curr Rheumatol Rep       Date:  2007-05       Impact factor: 4.592

7.  Identification of new autoantibody specificities directed at proteins involved in the transforming growth factor β pathway in patients with systemic sclerosis.

Authors:  Guillaume Bussone; Hanadi Dib; Mathieu C Tamby; Cedric Broussard; Christian Federici; Geneviève Woimant; Luc Camoin; Loïc Guillevin; Luc Mouthon
Journal:  Arthritis Res Ther       Date:  2011-05-13       Impact factor: 5.156

8.  IgG from patients with systemic sclerosis bind to DNA antitopoisomerase 1 in normal human fibroblasts extracts.

Authors:  Mathieu C Tamby; Amélie Servettaz; Nicolas Tamas; Joseph Reinbolt; Frédéric Caux; Olivier Meyer; Yannick Allanore; André Kahan; Loïc Guillevin; Luc Mouthon
Journal:  Biologics       Date:  2008-09

9.  In vitro and in vivo properties differ among liquid intravenous immunoglobulin preparations.

Authors:  F Dhainaut; P-O Guillaumat; H Dib; G Perret; A Sauger; C de Coupade; M Beaudet; M Elzaabi; L Mouthon
Journal:  Vox Sang       Date:  2012-09-25       Impact factor: 2.144

Review 10.  An innovative method to identify autoantigens expressed on the endothelial cell surface: serological identification system for autoantigens using a retroviral vector and flow cytometry (SARF).

Authors:  Tsuyoshi Shirai; Hiroshi Fujii; Masao Ono; Ryu Watanabe; Tomonori Ishii; Hideo Harigae
Journal:  Clin Dev Immunol       Date:  2013-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.